Active Ingredient: BUDESONIDE
Proprietary Name: BUDESONIDE
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: 3MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090379
Product Number: 001
Approval Date: Apr 2, 2014
Applicant Holder Full Name: BARR LABORATORIES INC SUB TEVA PHARMACEUTICALS USA
Marketing Status:
Discontinued
Patent and Exclusivity Information
